Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,578 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06825494RecruitingPhase 1/Phase 2
Study of a new drug for advanced solid tumors
This trial tests a new medication for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
Hefei, AnhuiAges 18 years+ - NCT06831942Recruiting
Suicide prevention counseling for adults 65 and older
This study tests a short counseling program for older adults (65+) who have recently attempted suicide or had serious suicidal thoughts. The program is designed to help reduce the risk of future suicide attempts. It is offered alongside your regular mental health care.
BoråsAges 65 years+ - NCT06406426RecruitingPhase 2
New drug combo for advanced stomach cancer after first treatment fails
This trial tests a combination of three drugs—cadonilimab, fruquintinib, and albumin-bound paclitaxel—as a second treatment for advanced stomach cancer. It may be an option if your first treatment stopped working and you have not had certain types of prior therapy.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT03666052Enrolling by invitation
Study for kids with severe nearsightedness in Shanghai
This study registers children and teens in Shanghai who have significant nearsightedness, to better track eye health over time. It may help researchers understand why high myopia develops and how to prevent or monitor complications.
Shanghai, Shanghai MunicipalityAges 4–18 - NCT07148466Recruiting
Shoulder and arm exercises for stroke with shoulder blade issues
This trial tests if specific shoulder and arm exercises can improve movement and walking in people who had a stroke and have shoulder blade problems. It may help if you have some muscle tightness but can still follow instructions.
Islamabad, Punjab ProvinceAges 40–65 - NCT06274138Enrolling by invitation
Haptonomy for bonding after infertility treatment
This study explores how a gentle touch therapy called haptonomy might help women who became pregnant through infertility treatment feel more connected to their baby and their partner. You would learn special touch exercises to do with your spouse during the last few months of pregnancy.
AnkaraAges 18 years+ - NCT07174115RecruitingPhase 2
Testing a new tablet for chronic sinusitis without nasal polyps
This trial tests an experimental tablet (HTMC0658) for people with chronic sinusitis that hasn't improved with standard nasal spray. You may join if your symptoms are moderate to severe and you've been using a stable dose of mometasone spray for at least 4 weeks.
Luoyang, HenanAges 18–75 - NCT06230471RecruitingPhase 2
Pembrolizumab plus lenvatinib or chemo for advanced bile duct cancer
This study tests whether adding another drug (lenvatinib or chemotherapy) to the immunotherapy drug pembrolizumab works better than pembrolizumab alone for advanced bile duct or gallbladder cancer that has not been treated before. It aims to find a more effective first treatment option.
Beijing, Beijing MunicipalityAges 18–80 - NCT06104215RecruitingEarly Phase 1
BGT007H cells for advanced digestive cancer
This trial tests a new cell therapy called BGT007H for people with advanced digestive tract cancers (esophagus, stomach, pancreas, or colon) that have not responded to or stopped working after at least two prior treatments. The goal is to see if this therapy can help shrink tumors or slow the disease.
Xuzhou, JiangsuAges 18–70 - NCT06101810Recruiting
Treatments to improve self-esteem
This study tests different treatments to help people who feel they have low self-esteem. You and your caregiver agree that low self-esteem is a problem for you.
Heerhugowaard, North HollandAges 18–65 - NCT06410313Recruiting
New drug-coated stent for thigh artery disease
This study tests a new drug-coated stent to improve blood flow in the thigh artery for people with leg pain or discomfort from narrowed arteries. It aims to see if the stent is safe and works well.
Atlanta, GeorgiaAges 18–120 - NCT06026423Recruiting
Stitching again vs. letting heal for perineal wound separation
This trial compares two approaches for women whose perineal stitches come apart after a second-degree tear or episiotomy: letting it heal on its own (conservative treatment) versus restitching. It aims to find which option leads to better healing.
HerlevAges 18 years+ - NCT06393179Recruiting
Breathing pattern study for ICU patients on ventilators
This study looks at a specific breathing pattern in very sick patients on a ventilator. Researchers want to find the best way to treat this pattern, which may help you breathe better and recover faster.
Nanjing, JiangsuAges 18 years+ - NCT06435780Recruiting
New gum graft technique for ridge repair
This trial tests a new, less invasive method to repair the gum ridge where a premolar tooth is missing. It compares the new technique to the standard gum graft procedure, with the goal of improving the area so a future dental implant or bridge can be placed.
CairoAges 18–50 - NCT06327477RecruitingPhase 1/Phase 2
A new type of radiation for newly diagnosed retroperitoneal sarcoma
This trial tests a new way of giving radiation called proton spatially fractionated radiotherapy (P-SFRT) combined with standard radiation for people with a type of sarcoma in the back of the belly. The goal is to see if this combination can treat the tumor more effectively.
Chicago, IllinoisAges 18 years+ - NCT06743945RecruitingPhase 2
Study of polatuzumab, rituximab, CHP for transformed DLBCL
This trial tests a combination of drugs (POLA-R-CHP) as a first treatment for patients whose large B-cell lymphoma has changed from a slower-growing type. It aims to see if this therapy is effective and safe for newly diagnosed patients.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT04456816RecruitingPhase 2
Drug test for IgA? No—anti-PLA2R positive immune kidney disease
This Phase 2 trial studies AP1189 in people with a specific immune-related kidney disease called iMN and very high urine protein. It aims to see whether the drug is safe and tolerable and if it can reduce protein in the urine.
AarhusAges 18–85 - NCT05428826RecruitingPhase 4
Stopping steroids early if PET/CT looks negative
This study tests whether some people with idiopathic retroperitoneal fibrosis can stop prednisone earlier when a PET/CT scan shows no concerning activity. It may reduce steroid side effects while keeping the disease under control.
Agen, FranceAges 18 years+ - NCT06737913RecruitingPhase 2
Study of adebrelimab and bevacizumab with liver chemo for advanced liver cancer
This trial tests a combination of an immunotherapy drug (adebrelimab) and a targeted therapy (bevacizumab) given through a vein or directly into the liver artery, along with standard chemotherapy directly into the liver artery, for people with advanced liver cancer that cannot be removed by surgery. The goal is to see if this approach can shrink or control the cancer.
Lanzhou, GansuAges 18 years+ - NCT03500133RecruitingPhase 4
Low-dose chemotherapy and less radiation for childhood Hodgkin lymphoma
This trial studies a treatment plan for children with classical Hodgkin lymphoma that uses lower total doses of chemotherapy and reduced radiation. The goal is to help control the lymphoma while lowering long-term side effects.
Buenos Aires, Buenos Aires F.D.Ages 2–18 - NCT06428448RecruitingPhase 2
Antibiotic nail for ankle infection treatment
This study tests a special antibiotic-coated nail placed inside the ankle bone to treat infections. It may help people with ankle infections avoid more serious complications.
Lansing, MichiganAges 21 years+ - NCT07102914Enrolling by invitation
Education program health survey study
This study looks at how a short program at adult education centers might help students and staff. It aims to understand what kind of support could be most useful for people working on their high school diploma or GED.
New Haven, ConnecticutAges 17 years+ - NCT06881056Recruiting
Aerosol interferon for RSV pneumonia in toddlers
This study tests an inhaled form of peginterferon alpha-2b for children aged 1 to 3 years who have pneumonia caused by RSV. The goal is to see if this treatment helps them recover faster.
Chengdu, SichuanAges 1–3 - NCT07066527Recruiting
New foam vs. standard foam for head and neck vein malformations
This study tests a new type of foam (polylauric alcohol foam) compared to standard foam for treating venous malformations (clusters of abnormal veins) in the head and neck area. The goal is to see if the new foam works better and is just as safe.
Jinan, ShandongAges 14–60
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,578 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.